| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Rockefeller University, New York, New York 10021
This paper describes the growth of HEp-3, a human epidermoid carcinoma, in the chick embryo. When inoculated onto the chorioallantoic membrane, the tumor grows locally with a doubling time of 21 to 24 hr and disseminates widely in the embryo proper, metastasis to the lung and heart being especially prominent. The tumor secretes large amounts of plasminogen activator (PA) both in vivo and in vitro. This enzyme of human origin can be easily identified in a mixture containing both human and chicken PA's, since each PA has a marked preference for the homologous plasminogen. Thus the presence of human PA in tissues and body fluids can be used as a quantitative marker for HEp-3 metastasis both in embryos and in newly hatched chicks.
Two assays for metastasis are described; their respective sensitivities are less than 4 x 104 and less than 500 HEp-3 cells per 17-day chick embryo lung (or approximately 1 HEp-3 cell per 400 and per 3 x 104 lung cells), respectively. These assays revealed that tumor growth and metastasis are sensitive to embryo age, inoculation onto the chorioallantoic membrane at 10 days being optimal for both. Tumor size, the length of the latent period that precedes the appearance of lung metastasis, and the number of metastatic cells in the lungs are all influenced by inoculum size. Generally, but not uniformly, an increased level of lung metastasis is correlated with tumor size on the chorioallantoic membrane. The attractive features of this system for quantitative study of metastasis are reproducibility, rapidity, sensitivity, convenience, and cost.
1 This study was supported by the American Cancer Society (Grant ACS PDT 1) and The National Cancer Institute (Grant CA08290).
2 To whom requests for reprints should be addressed.
Received 10/22/79. Accepted 4/ 7/80.
This article has been cited by other articles:
![]() |
J. J. Partridge, M. A. Madsen, V. C. Ardi, T. Papagiannakopoulos, T. A. Kupriyanova, J. P. Quigley, and E. I. Deryugina Functional Analysis of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Differentially Expressed by Variants of Human HT-1080 Fibrosarcoma Exhibiting High and Low Levels of Intravasation and Metastasis J. Biol. Chem., December 7, 2007; 282(49): 35964 - 35977. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Podgorski and B. F. Sloane Loss of Caspase-8 in Tumor Cells: Mechanism to Overcome Integrin-Mediated Death? Mol. Interv., June 1, 2006; 6(3): 132 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Deryugina, A. Zijlstra, J. J. Partridge, T. A. Kupriyanova, M. A. Madsen, T. Papagiannakopoulos, and J. P. Quigley Unexpected Effect of Matrix Metalloproteinase Down-Regulation on Vascular Intravasation and Metastasis of Human Fibrosarcoma Cells Selected In vivo for High Rates of Dissemination Cancer Res., December 1, 2005; 65(23): 10959 - 10969. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lugassy, H. K. Kleinman, J. A. Engbring, D. R. Welch, J. F. Harms, R. Rufner, G. Ghanem, S. R. Patierno, and R. L. Barnhill Pericyte-Like Location of GFP-Tagged Melanoma Cells: Ex Vivo and In Vivo Studies of Extravascular Migratory Metastasis Am. J. Pathol., April 1, 2004; 164(4): 1191 - 1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zijlstra, R. Mellor, G. Panzarella, R. T. Aimes, J. D. Hooper, N. D. Marchenko, and J. P. Quigley A Quantitative Analysis of Rate-limiting Steps in the Metastatic Cascade Using Human-specific Real-Time Polymerase Chain Reaction Cancer Res., December 1, 2002; 62(23): 7083 - 7092. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. HORINO, A. L. KINDEZELSKII, V. M. ELNER, B. A. HUGHES, and H. R. PETTY Tumor cell invasion of model 3-dimensional matrices: demonstration of migratory pathways, collagen disruption, and intercellular cooperation FASEB J, April 1, 2001; 15(6): 932 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Testa, P. C. Brooks, J.-M. Lin, and J. P. Quigley Eukaryotic Expression Cloning with an Antimetastatic Monoclonal Antibody Identifies a Tetraspanin (PETA-3/CD151) as an Effector of Human TumorCell Migration and Metastasis Cancer Res., August 1, 1999; 59(15): 3812 - 3820. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |